PATENT CLAIM ANALYSIS

Application Number: 16424382
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "470000"]

Abstract:
The present application provides a use of a nitric oxide releasing agent in preparing a medicament, wherein the medicament is used for preventing or treating EGFR inhibition associated epithelial diseases in a subject. The present application further provides a pharmaceutical composition or a kit comprising EGFR inhibitor and nitric oxide releasing agent.

Claim (Index 56):
The method of  claim 54 , wherein the concentration of the nitric oxide releasing agent in the medicament is from about 0.05% (w/w) to about 5.0% (w/w).

Metadata:
- Claim Count in Document: 35.0
- Percentile: 100.0
- Lexical Diversity: 1.48649
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10384499', '12659124', '15531677', '11717545', '15488116']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7853309132193582
- 35 USC 102 Novelty (BERT): 0.5066423546265325
- Combined Prediction Score: 0.7574620573600757
- Mean Citation Score: 228.84427
- Max Citation Score: 241.52232
- Similarity Product: 171.8564585901976

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test